Fresh from a Bloomerg news story comes this tidbit “Gilead Sciences Inc., whose $1,000-a-pill hepatitis C treatment is one of the world’s most expensive drugs, is avoiding billions of dollars in U.S. Taxes by booking profits overseas.” This is pure chutzpah and, it tells American consumers that we are going to put profits ahead of everything else and gives all of pharma a black eye.
Sigh…as I sit here and read the Tweets from ePharma I am once again reminded why pharma is lagging in digital marketing. I mean to say WebMD is the number one health portal on the web? Come-on everyone should know that, but what they also should know is that very few people go to WebMD and use that information for treatment decisions.
POST SUMMARY: CVS, the nation’s biggest health-related company with nearly $140 billion in annual sales , says this new strata of cholesterol drugs, believed to be a cut above previous medications, would severely strain the healthcare system if prescribed to all the 15 million Americans who could benefit from the drugs.
POST SUMMARY: Less than 10% of those surveyed use the web, email or text to set up appointments with doctors. And only 21% use the web to look at their health data. This lack of modern technology could at least partly be responsible for challenges around preventative care in America, as 40% of respondents said they receive no ongoing care recommendations from their physician.
POST SUMMARY: From spending too much on sales and marketing to deception of clinical trials the pharma industry is being attacked by a media that is looking to channel consumer anger rather than explore an unbiased balanced article. It’s time for the industry to fight back because there are too many really good people working within it to try and help patients lead a better life.